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Equine Gastric Ulcer Syndrome affects roughly 90% of performance horses. The 
only reliable antemortem diagnostic method is endoscopy, which is an invasive process. 
The cornerstone of treatment is acid suppression, a cost-prohibitive option that is not 
viable for long-term use. The objectives of this study were to investigate the efficacy of a 
polysaccharide (PS) supplement on gastric ulcers in the squamous (SQ) and glandular 
(GL) regions of the equine stomach and identify associated serum and salivary 
biomarkers. It was hypothesized that severity of SQ and GL ulcers throughout the 
supplemental period would decrease and levels of serum and salivary proteins, as well as 
total antioxidant capacity (TAC), would fluctuate with ulcer scores. To test this 
hypothesis, 8 mature geldings were randomly assigned to a PS-supplemented (TRT) or 
non-supplemented (CTRL) group once they underwent ulcer induction using a modified 
Murray method: alternating 12- and 24-hr feed deprivations for a total of 108hr. 
Following the induction, TRT horses’ feed was top-dressed with 1oz of PS supplement 
twice daily. Horses were fed 1.0% BW in Fescue hay (Festuca pratensis) and 0.25% BW 
in concentrates daily (Nutrena® Triumph® Fiber Plus, Cargill®, Inc., Holmesville, OH) 
with ad libitum water access, as recommended by the NRC. Horses were housed in 
3.05x3.65m stalls and 4 were turned out per 0.809ha pastures from 0600-1800hrs and 
1800 to 0600hrs, respectively. Pastures were composed of Fescue (Festuca pratensis), 
rye (Lolium multiflorum), clover, and other native grasses. The experiment was divided 
into 3 periods: pre- (Day 0), mid- (Day 28), and post-supplementation (Day 42). Per 




were collected. The effects of time and treatment were analyzed with a factorial 
ANOVA. All statistical calculations were performed using the software JMP. The 
severity of ulcer scores decreased in all horses over the 6-week timespan (P=0.001), with 
no difference found in ulcer scores between TRT and CTRL horses in the SQ or GL 
regions. It is possible that the body’s innate healing capacity was adequate in this study, 
which may have masked the treatment effect of the PS supplement. There was a 
correlation found between salivary TAC (R2=0.559; P=0.005) and serum TAC 
(R2=0.620; P=0.002) and ulcer score, which may indicate a shift in oxidative stress 
factors as ulcers heal. The investigation of polysaccharide supplementation as a 
preventative measure in ulcerative and non-ulcerative horses under stress is warranted. 
Additionally, the exploration of other salivary and serum biomarkers to further develop a 

















 Thank you to BioZyme®, Inc. for supplying the product and monetary gift that 
funded this research. I greatly appreciate Dr. Lynsey Whitacre, Dr. Ignacio Ipharraguerre, 
and Ana Gutiérrez Montes for their assistance with experimental design and analysis.  
 Dr. Alexandra Tracey and her team at Palmetto Equine Veterinary Services, thank 
you for performing a multitude of endoscopies and taking the time to capture quality 
photos of each horse’s gastric abnormalities.  
 I am very grateful for the support from my Clemson community. Dr. Kristine 
Vernon has been academically guiding me for six years, and I cherish and respect her 
advice in and out of academia. Dr. William Bridges, my statistician, tolerated countless 
meetings to ensure we made the most use of the data. Thank you to my other committee 
members, Dr. Elliot Jesch and Dr. Shannon Pratt Phillips, for their aid in experimental 
design and data interpretation. Julia Gentry and the staff at Clemson University Equine 
Center, thank you all for your care taken in the execution of protocol. 
 Lastly, thank you to friends and family that have provided their support. Your 
unwavering faith in me, willingness to give advice, and strength to hold me accountable 























LIST OF TABLES………………………………………………………………………..vi 
 




 I. LITERATURE REVIEW……………………………………………………..1 
 
 II. EQUINE GASTRIC ULCERS: POLYSACCHARIDE  
   SUPPLEMENTTION AS A SOLUTION……………………………….27 
 
 III. EQUINE GASTRIC ULCERS: ASSOCIATED BIOMARKERS…………..42 
 
 IV. SUMMARY………………………………………………………………….54 


























































 2.1 Gastric ulcer scores on day 0, 21, and 42 of polysaccharide supplemented      
  (TRT; n=4) versus non-supplemented horses (CTRL; n=4)…………………33 
 
 2.2 Gastric ulcer scores on day 0, 21, and 42 of all experimental horses (n=8)…33 
 
 2.3 Squamous (SQ) versus glandular (GL) gastric ulcer scores on day 0, 21, and  
  42 of all experimental horses (n=8)………………………………………….34 
 
       2.4a Squamous (SQ) gastric ulcer scores on day 0, 21, and 42 of polysaccharide   
  supplemented horses (TRT; n=4) versus non-supplemented horses (CTRL; 
  n=4)…………………………………………………………………………..34 
 
       2.4b Glandular (GL) gastric ulcer scores on day 0, 21, and 42 of polysaccharide 
  supplemented (TRT; n=4) versus non-supplemented horses (n=4)………….35 
 
       2.5 Ulcer scores in various regions (margo plicatus (MP), non-margo plicatus 
  (NMP), pylorus (P), and non-pylorus (NP)) on day 0, 21, and 42 of all 
  experimental horses (n=8)…………………………………………………...36 
 
       2.6  pH values of the proximal (P) and distal (D) regions of the equine stomach on 
  day 0, 21, and 42 of all experimental horses (n=8)…………………………..37 
    
       3.1  Salivary adenosine deaminase (ADA) concentrations from day 0, 21, and 42  
  sample collections in polysaccharide supplemented (TRT; n=4) and  
  non-supplemented (CTRL; n=4) with glandular (GL) ulcers………………..48 
   
       3.2 Salivary total antioxidant capacity (TAC) concentrations in polysaccharide   
  supplemented (TRT; n=4) and non-supplemented horses (CTRL; n=4) with   
  glandular (GL) ulcers………………………………………………………...49 
        
 3.3 Serum total antioxidant capacity (TAC) levels in polysaccharide 
  supplemented (TRT; n=4) and non-supplemented (CTRL; n=4) with 
  squamous (SQ) ulcers………………………………………………………..50 
 
       3.4 Serum adenosine deaminase (ADA) levels in polysaccharide supplemented   
  (TRT; n=4) and non-supplemented horses (CTRL; n=4) with glandular  










       3.5  Serum total protein (TP) levels in polysaccharide supplemented (TRT; n=4)  










 The term Equine Gastric Ulcer Syndrome (EGUS) was first used in 1999 to 
describe gastric ulceration in the horse (Andrews, 1999). Termed by the Equine Gastric 
Ulcer Council (EGUC), EGUS is defined as the disease complex that is associated with 
ulceration of the esophageal, gastric, or duodenal mucosa. Misuse of this term is common 
and the EGUC emphasized the importance of distinguishing between diseases of the 
squamous (SQ) and glandular (GL) mucosa, as their pathophysiology and treatment 
needs differ greatly (Merritt, 2009). Thus, the term EGUS is used as an all-encompassing 
term to describe ulcerative and erosive diseases of the equine stomach, Equine Squamous 
Gastric Disease (ESGD) describes ulcerations of the SQ mucosa, and Equine Glandular 
Gastric Disease (EGGD) describes ulcerations of the GL mucosa. ESGD can be further 
categorized as primary, the more common form, or secondary. Animals diagnosed with 
primary ESGD have an otherwise normal gastrointestinal (GI) tract and those diagnosed 
with secondary ESGD have an underlying gastric abnormality. Specifications of EGGD 
are lacking, thus it is recommended to diagnose ulcerations according to their anatomical 
location (cardia, fundus, antrum, or pylorus) and the appearance of the lesion (Sykes et 










Squamous mucosa  
  
 The degree that stratified SQ mucosa extends from the esophagus into the 
stomach varies between domestic species. In horses, it is the proximal one half of the 
stomach, which is histologically composed of 4 major zones: stratum corneum, stratum 
transitionale, stratum spinosum, and stratum basale. No mucus cells are present within 
these layers. The main function of the metabolically active layers below the stratum 
corneum is active Na+ transport, operated by Na+-K+ATPases (Chien and Stevens, 1972). 
The SQ mucosa’s high electrical resistance aids in barrier function, prohibiting 
penetration by large molecules. There is a minimal barrier of tight junctions present in the 
stratum corneum, which is supported further by the principal barrier of the stratum 
spinosum. Once past the latter barrier, there is minimal resistance to the penetration of 
large molecules (Orlando, 1991). Weak acids, such as short chain fatty acids (SCFA) that 
result from microbial digestion of carbohydrates, are also considered weak electrolytes. 
This allows their rapid diffusion across the mucosal barrier as luminal pH decreases, 
which in swine has been found to irreversibly insult the current of Na+ transport that 
results in a decrease in electrical resistance, thus indicating the reduction of barrier 
function. The process of injury to SQ mucosa via SCFA progresses from penetration of 
the outer barrier, acidification of the underlying transport cells, elimination of the short 
circuit current, cell swelling, to a fall in electrical resistance. Contrarily, injury from a 




transporting cells via exposure to H+, diminished cell volume regulation, cell swelling, 
and eventual necrosis (Argenzio, 1999; Carney et al., 1981).  
Glandular mucosa   
 
 The pathophysiology of EGGD is less understood, as the mucosa of the GL region 
functions differently than the SQ mucosa. The GL mucosa consists of a mucus-
bicarbonate layer on the epithelium surface, which is responsible for titrating incoming 
luminal H+ ions to CO2 and H2O (Flemstrong, 1994). Unlike SQ mucosa, GL mucosa has 
varying capacity to heal by migration of healthy tissue to the site of injured tissue, a 
process denoted as restitution (Silen, 1987). Another difference between the mucosa is 
the protective properties of prostaglandins for the GL region, which aid in increased 
blood flow as well as mucus and bicarbonate secretion (Orlando, 1991). Under normal 
physiological health, the GL mucosa is constantly exposed to acidic pH levels (1-3) and 
has the capacity to function in this condition. Thus, EGGD occurs when the natural 
barriers of the GL mucosa are broken down and defense mechanisms fail. These 
mechanisms that contribute to the breakdown have not been elucidated in the horse and 
are of interest (Merritt et al., 2003). 
 The role of bacteria in EGGD is controversial. It is unknown whether gastric 
bacteria and pathogens play a role in GL ulceration as they do in the SQ region. In some 
studies, horses affected by EGGD had the presence of Helicobacter-like organisms 
(Contreras et al., 2007; Fox, 2002), where in others there was failure of identification 




 The role of non-steroidal anti-inflammatory drugs’ (NSAIDs) cause in EGGD is 
also controversial. At doses 50% higher than recommended flunixin, phenylbutazone, 
and ketoprofen have proven to have ulcerogenic capacity (Cg et al., 1993). However, 
when administered at clinical doses for 15 days, phenylbutazone and suxibuzone did not 
induce gastric ulcers (Andrews et al., 2009).  
Prevalence  
 The prevalence of gastric ulceration varies with breed, use, level of training, as 
well as between ESGD and EGGD (Andrews et al., 2009). Thoroughbreds represent the 
highest portion of horses diagnosed with ESGD, affecting 37% of untrained and 80-100% 
of those who undergo race training for 2-3 months (Begg and O’Sullivan, 2003; Murray 
et al., 1996; Vatistas et al., 2010). Similarly, the percentage of ESGD increases from 44% 
in non-training to 87% with training in Standardbred horses (Dionne et al., 2003; Jonsson 
and Egenvall, 2006; Rabuffo et al., 2002). Additionally, around 17-58% of show/sport 
horses and 37-59% of pleasure horses are affected (Hartmann and Frankeny, 2003; 
Luthersson et al., 2009a; McClure et al., 1999; Murray et al., 1989; Niedźwiedź et al., 
2013). Outside of competition season, around 48% of endurance horses have been found 
to be affected by ESGD, while 66-93% of those in the midst of competition season are 




that do not commonly travel or compete have an 11% prevalence of ESGD (Chameroy et 
al., 2006).  
Research on the prevalence of EGGD is not as thorough. Prevalences between 
47% and 65% have been reported in Australian Thoroughbred horses and between 16% 
of non-competitive endurance horses and 27-33% of competitive endurance horses (Begg 
and O’Sullivan, 2003; Nieto et al., 2004; Sykes et al., 2015b; Tamzali, 2011). In the 
United Kingdom, a reflective study found 54% of 191 leisure horses and 64% of 493 
sport horses had EGGD (Hepburn, 2005). Similarly, in 2 separate studies, 57% of horses 
used for a variety of purposes were reported to have EGGD (Husted et al., 2010; 
Luthersson et al., 2009a). For each of the previously mentioned studies involving EGGD, 




 There is conflicting evidence surrounding the capability of pasture turnout to 
reduce the risk of EGUS. While grazing, the horse’s continuous secretion of saliva and 
influx of ingesta act to buffer stomach acid. When feed access is intermittent, gastric pH 
drops, exposing the SQ mucosa to an acidic environment (Buchanan and Andrews, 
2004). One particular study involving Thoroughbred horses in training found that horses 
in turnout were less likely to have ESGD, and those turned out with the company of other 
horses had an even lower risk (Lester et al., 2007). On the contrary, a separate study on 




on ESGD risk (Bell et al., 2007). An additional study’s findings suggested that pasture 
turnout on its own might not affect gastric pH. This was based on a lack of intragastric 
pH difference in horses fed ad libitum grass hay and grain twice per day (1 kg/100 kg/d) 
when they were housed in a grass paddock, in a stall on their own, or in a stall with an 
adjacent companion (Husted et al., 2008). 
 Free access to fibrous feed or frequent forage feeding is widely considered to 
reduce the risk of gastric ulceration (Sykes et al., 2015a). At a minimum, those receiving 
hay should be offered 1.5% of their bodyweight per day (Videla and Andrews, 2009). 
Horses and ponies that are overweight and at risk of EGUS should be offered hay that is 
mature with a low energy content. If there is no low-energy hay available, a mixture of 
high-quality hay and straw can be offered, but straw should not be the only forage 
provided, as it is suggested that forage type is an important factor in the prevention and 
management of EGUS. When attempting to raise gastric pH and decrease peptic injury, a 
diet consisting of alfalfa hay and grain was found to be more effective than a diet absent 
of grain and consisting solely of brome grass hay or coastal Bermuda hay (Lybbert et al., 
2007; Nadeau et al., 2000). Adding to that suggestion, there is an increased likelihood of 
ESGD when straw is the sole forage provided (Luthersson et al., 2009a). In addition, the 
impact of forage feeding in the absence of alternate risk factor reduction might not be as 
effective as previously thought. In one study, both the number and severity of ESGD 
lesions were greater in the high-fiber group in comparison with the group fed an iso-




ESGD is increased when time intervals between forage meals increases (Luthersson et 
al., 2009a).   
 Consistently, it has been found that there is an increased risk of ESGD in animals 
working at various levels of intensity that have an increased starch/grain intake. When 
non-exercising horses are stabled and fed grain at 1% of BW one hour before hay is 
given, there is a notable increase in ulceration (Frank et al., 2005). Furthermore, there is 
an approximately two-fold increased risk of ESGD in horses fed amounts exceeding 
2g/kg BW of starch intake per day (Luthersson et al., 2009a). Horses maintaining a 6 
kg/d diet of grain that entered an artificial training regimen and stabling after being 
removed from pasture developed ESGD within 14 days (Vatistas et al., 1999). High 
concentrate diets are typically high in non-structural carbohydrate, such as starch. In the 
process of starch digestion by fermentation via residential bacteria, VFAs are produced. 
The presence of VFAs in a stomach with a pH ≤4 directly causes acid damage to SQ 
mucosa (Nadeau et al., 2003). Diets higher in protein and calcium (alfalfa hay/grain) have 
resulted in less severe gastric ulcers when compared to a low protein and calcium diet 
(brome grass hay), indicating a potential protective effect of alfalfa hay on the SQ 
mucosa (Buchanan and Andrews, 2004). 
 Another factor increasing a horse’s risk of developing EGUS is intermittent 
access to water. It has been shown that horses without water access are over 2.5 times 




2009a). Interestingly, this risk factor applied to all portions of the stomach, as opposed to 
solely affecting the SQ mucosa.  
Exercise  
 
 The relationship between training or racing and prevalence is significant, as 
approximately 60-90% of performance horses suffer from EGUS (Buchanan and 
Andrews, 2004). When the horse is at a gait faster than a walk, the increased intra-
abdominal pressure and decreased stomach volume causes acidic gastric contents to push 
up to the level of the SQ mucosa, resulting in prolonged exposure of the mucosa to acidic 
gastric contents (Lorenzo-Figueras and Merritt, 2002). Daily exercise may contribute to 
increased exposure of the SQ tissue to acidic gastric contents, explaining the increased 
prevalence of gastric ulcers in horses in training (Buchanan and Andrews, 2004). 
Additionally, significant association has been found between increased interval training 
for long durations and increased prevalence of lesions, lesion severity, and number of 
lesion sites (Murray et al., 1996; Orsini et al., 2009; Roy et al., 2005). In elite endurance 
horses, there is a direct correlation between distance of ride and severity of ESGD 
(Tamzali, 2011).  
Transportation  
 The increased incidence of EGUS in horses that are regularly transported is likely 
due to decreased access to feed and water. Additionally, transportation is associated with 
dehydration and immune suppression, potentially contributing to overall health decrease 
(Watson, 2002).  




 The influence of stall confinement on the development of gastric ulcers is likely 
multifactorial, as intermittent feeding and restriction of exposure to other horses are 
common in those that are housed in stalls. However, one study did find that horses 
housed in pastures have a decreased prevalence when compared to horses confined to 
stalls (Fiege et al., 2002).  
Nonsteroidal anti-inflammatory drugs  
 It has been proven that various NSAIDs cause gastric ulcers in horses (MacAlliser 
and Sangiah, 1993). Abundant studies in Thoroughbred racehorses have contradicted this, 
each coming to the conclusion that the use of NSAIDs in racehorses is not a risk factor 
for EGUS (Johnson et al., 1994; McClure et al., 1999; Murray et al., 1996; Rabuffo et al., 
2002; Vatistas et al., 2010). However, another study found that NSAIDs did cause ulcers 
of the GL mucosa and increased the severity of ulcers of the SQ mucosa (MacAlliser et 
al., 1992). NSAIDs are thought to have a greater negative impact on GL mucosa due to 
their role in prostaglandin inhibition, which results in decreased mucosal blood flow, 
decreased mucus production, and increased HCl secretion. The regulation of acid 
production, Na+ transport, and mucosal blood flow by prostaglandins is crucial to GL 
mucosal integrity, with adequate blood flow likely being the most influential. Its aid in 
the removal of diffused H+ ions through the mucus layer is critical (Barr, 2001; Murray, 
1991).  
Helicobacter spp 
 There are controversial findings concerning the influence of Helicobacter pylori 




DNA from both the SQ and GL mucosa of seven horses with ulcers, while other 
postmortem reports of horses with and without EGUS lacked any presence of related 
organisms (Johnson et al., 1994; Scott et al., 2001). Nevertheless, adjunctive therapies 
along with acid suppression may be beneficial for the treatment of gastric ulcers in 
horses, as it is such in other species.  
 
Clinical Signs  
 
 Individual cases of EGUS often present with a large range of vague clinical signs. 
The most seen at the population level is reduced appetite and poor body condition. It is 
common that behavioral inconsistencies such as nervousness, aggression, and self-
mutilation occur alongside ulcer presence. Considering the numerous factors that play a 
role, it is fair to say EGUS might result in reduced performance, but other components 
should also be addressed. It is not advisable to diagnose EGUS via clinical signs, but to 
definitively diagnose the syndrome via endoscopy (Scott et al., 2001).  
Colic 
 There is evidence suggesting that gastric ulcers are associated with an increased 
likelihood of colic and postprandial abdominal upset (Murray, 1992; Murray et al., 1989; 
Sandin et al., 2000; Vatistas et al., 2010; Videla and Andrews, 2009). In one study, it was 
reported that 83% of horses with recurrent colic had gastric ulcers after undergoing 
suppressive acid treatment (Murray, 1992). Additionally, a study found that 3.5% of 
horses that exhibited colic in the preceding month had ESGD and another reported that 
49% of horses presenting acute colic had ESGD (Vatistas et al., 2010). In the latter study, 




ESGD in comparison to those that underwent surgical management (Dukti et al., 2006). 
Though uncertain, the difference in rates of ESGD between the two groups might be 
attributable to medically-managed horses undergoing longer periods of fasting 
(Berschneider et al., 1999; Murray, 1996).   
Poor coat condition 
 Results concerning an association between poor hair coat and gastric ulceration 
are contradicting. There have been studies that found statistical association between the 
two, while there have also been studies that failed to identify an association (Dionne et 
al., 2003; le Jeune et al., 2009; Vatistas et al., 2010).  
Diarrhea 
 There is no definitive cause-and-effect relationship between diarrhea and gastric 
ulceration, though it has been reported as a clinical sign in adult horses (Murray et al., 
1989). Moreover, it is likely that when there is an association between diarrhea and 
gastric ulceration, there is a wider disease process occurring (Sykes et al., 2015a).  
Stereotypical behaviors  
 Commonly, horses demonstrating altered or stereotypic behavior are likely to 
present gastric ulcerations (Andrews and Nadeau, 1999; Murray et al., 1989). For 
instance, competition horses with a nervous disposition tend to present ESGD more often 
than quiet, normally-behaved horses (McClure et al., 1999). In addition to nervousness, 
behavioral changes may include aggression and self-mutilation, which are behaviors such 
as biting, stomping, and kicking (McDonnell, 2008). Some data from racehorses has 




interestingly showed correlation between aggression and ESGD (Lester et al., 2007). 
Additionally, there is a correlation between cribbing and ESGD, though the biological 
mechanism behind it is uncertain (Nicol et al., 2002).  
Decreased performance 
 While poor performance is one of the most influential signs of ESGD, its 
investigation is lacking. The particular question is if gastric ulcers directly cause poor 
performance, rather than indirectly due to other clinical signs such as reduced appetite or 
weight loss. It is most likely that reduced performance is linked to gastric pain (Andrews, 
2008). Ulcerations of the SQ mucosa in horses are similar to lesions that cause heartburn 
or gastroesophageal reflux disease (GERD) in humans. In one study it was found that 
58% of elite athletes suffering from GERD reported upper GI pain during exercise, with a 
proportional increase with intensity (Lj and Df, 1985). Additionally, human runners with 
GERD experience decreased time to exhaustion when compared to runners without the 
disease (Rodriguez-Stanley, 2006).  
 In racehorses, there has been limited research to provide an association between 
performance and the presence of ulcers. Performance measurements vary from trainer 
observation to objective physiologic responses through treadmill testing. It has been 
found that, independent of the quantity and severity, there is an association between poor 
performance and ESGD (Vatistas et al., 2010). Similar results have been found 
concerning Standardbred racehorses, showing an association between ESGD presence 
and reduced performance (Jonsson and Egenvall, 2006). A small trial consisting of 4 




that there was improved performance with omeprazole treatment (Franklin et al., 2008). 
Within poor performance, it is postulated that abdominal pain caused by gastric ulcers 
might affect stride length and ventilation. Intermittent feed deprivation was applied to a 
population of horses in order to induce gastric ulcers, followed by half of the study 
population receiving omeprazole treatment and half receiving no treatment. With 
incremental treadmill exercise testing, physiological responses were recorded, and it was 
found that treatment horses had increased time to fatigue and longer stride length when 
compared to untreated horses (Nieto et al., 2009).  
Diagnostics 
 Endoscopy is the only reliable antemortem method of diagnosing EGUS. 
Preparation for endoscopy includes feed and water restrictions, as well as sedation. If 
necessary, before alterations to the gastric environment are made, stomach fluid samples 
are collected via aspiration. During the endoscopic procedure, the stomach is distended 
by the insufflation of air through the endoscopy biopsy channel until the SQ and GL 
regions of the gastric mucosa are visible. Gastric contents are thoroughly rinsed from the 
stomach surface using tap water flushed through the biopsy channel. Throughout the 
endoscopy, images are captured and digitized with a portable personal computer. At the 
conclusion of this procedure, the endoscope is withdrawn, and horses are appropriately 
recovered from sedation. When performing endoscopy, visualization of the entire 
stomach is crucial as the presence or absence of ESGD or EGGD cannot be used to 




 Currently, there are no definitive hematological or biochemical markers found to 
reliably aid in the diagnosis of EGUS. Though the diagnostic accuracy is not clinically 
reported, sucrose permeability shows promise for a noninvasive diagnostic method of 
gastric ulcers (Hewetson et al., 2006; O’Conner et al., 2004). There have been attempts to 
correlate gastric ulcer presence with fecal albumin or hemoglobin, however no significant 
association has been found (Pellegrini, 2005; Sykes et al., n.d.).  
Ulcer Grading 
After ulcer presence is identified by endoscopy, severity of the lesions must be 
assessed. There are several methods of assigning ulcer grades, the most common being 
one that describes the mucosal appearance as well as anatomical location. Grading scales 
range from 0-3 to 0-10 in various publications (Andrews et al., 1999; Murray et al., 
1996). The EGUC recommends utilizing the existing 0-4 scoring system to be used for 
ESGD and EGGD in order to provide clinical and research uniformity. The importance of 
stating the anatomical location, distribution, and appearance of lesions in the GL portion 
of the stomach has been emphasized, as the use of a definitive grading scale is 
controversial. Thus, the grading of the ulcers initially indicates whether the horses have 
ESGD or EGGD. Following this, lesion scores are assigned and range from 0-4 for each 
of the ulcer types. For ESGD, 0 indicates the epithelium is intact and there is no 
appearance of hyperkeratosis, 1 indicates the mucosa is intact but there are areas of 
hyperkeratosis, 2 indicates small, single, or multifocal (<5) superficial lesions, 3 indicates 
large single deep, or multiple (³5) focal superficial lesions, and 4 indicates extensive 




intact and there is no evidence of hyperemia, 1 indicates the mucosa is intact but there are 
areas of hyperemia, 2 indicates small, single, or multifocal (<5) superficial lesions, 3 
indicates large single deep or multiple (³5) focal superficial lesions, and 4 indicates 
extensive lesions with areas of apparent deep ulceration (Sykes and Jokisalo, 2014, p. 1). 
Treatment and Prevention 
 Commonly, empiric treatment is administered when endoscopy is unavailable. 
Due to cost and importance of distinguishing between ESGD and EGGD, treatment 
without definitive diagnosis is not recommended. However, if treatment is administered 
empirically and there is a failure to respond, endoscopy should still be performed to rule 
out gastric disease. 
Pharmaceutical Therapy  
Antacids  
 Antacids are mainly effective through neutralizing stomach HCl, but aluminum-
containing formulas have potential for added mucosal protective effects through the 
stimulation of prostaglandin production. There are mixed conclusions on their efficacy of 
controlling stomach pH (Szelnenyi et al., 1989). Varying compositions and 
administrations of aluminum hydroxide and magnesium hydroxide were found to have 
short-term effects on stomach pH (Clark et al., 1996; Murray and Grodinsky, 1992). It 
has been gathered that efficacy of antacid administration seems dependent on frequent, 
large doses, which may impact electrolyte absorption. There is slight symptomatic relief 
from antacids, but the longevity of their efficacy is poor. The effects last £2 hours, 




Grodinsky, 1992). Thus, administering antacids may be beneficial for relieving clinical 
signs of EGUS, but are not likely effective in healing gastric ulcers (Buchanan and 
Andrews, 2004).  
Histamine type 2 receptor antagonists 
 Acid secretion from parietal cells is stimulated by histamine. Histamine type 2 
(H2) receptor antagonists bind to the histamine receptor, thus decreasing acid secretion by 
blocking histamine from attaching. The H2 receptor antagonist may also be proficient in 
inhibiting gastric acid secretions caused by gastrin and acetylcholine (Brunton, 2000). 
Cimetidine and ranitidine are the most reviewed H2 receptor antagonists. Cimetidine is 
not extremely effective and ranitidine is more commonly used, as it is four times more 
potent (Ross et al., 1981). Efficacy of ranitidine is dose-dependent, and in certain cases 
may suppress acid output and maintain a stomach pH of 4.6 (Holland et al., 1997; 
Johnson et al., 2001; Murray and Schusser, 1993). 
Proton pump inhibitors 
 Currently, the cornerstone of gastric ulcer treatment is acid suppression in both 
ESGD and EGGD. Omeprazole is the most well-reviewed proton pump inhibitor used for 
the treatment of gastric ulcers in horses. It works by impairing the H+-K+ATPase pump 
that secretes HCl (Clark et al., 1996). Currently, omeprazole it is the only FDA-approved 
drug for EGUS treatment and is usually the drug of choice. It is effective only when 
formulated to withstand the acidic environment of the stomach to avoid premature 
degradation. Common methods of obtaining this formula include a buffered paste or 




2014). Overall, findings suggest that doses of omeprazole, either buffered or enteric 
coated, are efficacious and warrant consideration.  
 When introduced to an acidic environment, omeprazole is activated to a 
sulfonamide derivative and subsequently binds reversibly to H+-K+ATPase in parietal 
cells. This results in the inhibition of H+ ion transport into the cell, hence its classification 
as a proton pump inhibitor (Plumb, 2002). Omeprazole is metabolized in the liver and 
excreted in the urine and bile, therefore horses with significant liver disease may 
metabolize the drug at different rates. In other species, long-term administration has not 
caused clinical, hematologic, or biochemical alterations, however, it has caused a 
reversible gastric mucosal hypertrophy (Sundell and Nillsson, 1986), hyperplasia of 
enterochromaffin-like (ECL) cells, and gastric carcinoid tumors (Tielemans et al., 1989). 
In horses, no significant side effects have been reported when treated for up to 90 days. 
 The required duration of acid suppression to allow for healing of ESGD and 
EGGD has not been defined in horses. Previous literature suggests that once daily 
administration of omeprazole results in 24 hours of acid suppression, but recent studies 
have countered this belief with finding acid suppression as short as 12 hours in some 
animals (Daurio et al., 1999; Jenkins et al., 1992). Even so, based on several studies, 12-
hour acid suppression is sufficient for ESGD treatment. Another consideration to be 
made is the duration of treatment. The standard omeprazole treatment is 28 days, but it 
has been found that healing of ESGD has occurred in 21 days (Murray et al., 1997). Even 
within the standard 28-day treatment, it is important to note that only approximately 70-




1997). Thus, follow-up endoscopies must be continued until treatment has ceased to 
ensure proper healing has occurred.  
 Treatments pertaining specifically to EGGD have not been considered until 
recently. The difference in the healing process of the SQ and GL tissue warrant treatment 
investigation. In a recent study where 28-35 days of omeprazole treatment was 
administered, only 25% of EGGD lesions healed whereas ESGD lesions had a 78% 
healing rate (B. W. Sykes et al., 2014a, 2014b; Sykes et al., 2015b). It is possible that 
EGGD lesions might require longer treatment periods. In humans, the duration of 
treatment for GL ulcerations depends on the cause of the injury, but is typically 8 and 12 
weeks for 84% and 100% healing rates for ulcers induced by NSAIDs (Lancaster-Smith 
et al., 1991). Healing rates of EGGD have been observed to be around the same time 
frame; however, clinical trials tailored to this topic are lacking (Sykes et al., 2015a). In 
addition to the possibility of longer treatment duration requirements, the role of bacteria 
in EGGD should be examined. If bacteria play a factor in the development of EGGD, 
omeprazole monotherapy might be inadequate, and the use of adjunctive therapies should 
be considered. In humans, ulcerations associated with H. pylori call for triple treatment, 
including antimicrobials. This results in healing rates >80% (Malfertheiner et al., 2009). 
Theorizing from this, antimicrobial treatment in the horse for EGGD is popular. 
However, antimicrobials do not improve healing of non H. pylori ulcerations in humans, 
therefore no evidence exists to support their use in horses for healing EGGD 





Coating or binding agents  
 The use of mucosal protectants for the treatment of EGGD is warranted given the 
suggested role of mucosal defense failure in the development of GL lesions. The mucosal 
protectant backed by the most research is sucralfate, which functions by adhering to 
ulcerated mucosa as well as stimulating mucus secretion, prostaglandin E2 synthesis, and 
blood flow, all of which are beneficial to the healing process of EGGD (Murray, 2017). 
The hydroxyl aluminum salt of sucrose octasulfate becomes adhered due to the negative 
charge of the ulcer bed, resulting in the secretion of bicarbonate that buffers HCl (Borne 
and MacAllister, 1993). Additionally, once in the stomach, sucralfate is converted to a 
sticky amorphous mass that may aid in the inhibition of H+ diffusion into the ulcer. The 
efficacy of sucralfate alone is extremely variable. In combination with omeprazole 
treatment, it has resulted in healing rates of 67.5% in the pyloric antrum, which is one of 
the most common and resistant areas of ulceration in the GL region of the stomach 
(Hepburn and Proudman, 2014).  
Antibiotics 
 In humans, ulcerations associated with H. pylori call for triple treatment including 
antimicrobials. This results in healing rates >80% (Malfertheiner et al., 2009). 
Combination therapy has been most effective in other species, pairing acid suppressive 
therapy with antibiotics (Hall, 2000). Theorizing from this, antimicrobial treatment in the 
horse for EGGD is popular. However, antimicrobials do not improve healing of non H. 
pylori ulcerations in humans, therefore no evidence exists to support their use in horses 




Nutraceutical Therapy  
Pectin-lecithin complex 
 The ease of use and availability of nutraceuticals are appealing, but they provide 
mixed results. Increased total mucus concentration in gastric juice has been found in 
studies investigating pectin-lecithin complexes (Koeller, 2010). Contradicting this, two 
studies involving pectin-lecithin complexes did not find a protective effect in horses with 
ESGD (Venner et al., 1999). More recently, showing promise for treatment of ESGD and 
EGGD simultaneously is a combination of an antacid (magnesium hydroxide), a pectin-
lecithin complex, and Saccharomyces cerevisiae (Sykes et al., 2014).  
B vitamin complex 
 There has been promise of ESGD management by a feed supplement consisting of 
B vitamins combined with organic salts as well as possible EGGD prevention via sea 
buckthorn berries (Hellings and Larsen, 2014; Huff et al., 2012).  
Corn oil 
 Arachidonic acid precursors, such as linoleic acid, have been investigated for their 
ability to increase endogenous prostaglandin production and decrease maximally 
stimulated acid output (Grant et al., 1988; Mandel et al., 1994; Schepp et al., 1988). 
There is interest in the potential role of prostaglandins, specifically those of the E series, 
to provide mucosal protection and potential therapeutic value as they have been found to 
have anti-ulcer properties (Lanza, 1989; Wilson, 1988). In studies involving humans and 
rats, it has been found that dietary supplementation with linoleic acid increased the  




1988; Schepp et al., 1988). Additionally, rats induced via cold, restraint, and ethanol 
administration had significantly reduced mucosal lesions when fed a linoleic-
supplemented diet (D and A, 1991; Mandel et al., 1994; Schepp et al., 1988). Corn oil 
supplementation is an economical approach to management of the equine GL mucosa, 
especially when injury is caused by NSAID usage.   
Gastrocure 
 Gastrocure is a natural feed supplement composed of Plantago ovate (Fleawort 
extract), Trigonellafoenum-graecum (Fenugreek extract), Aloe Vera, and Glycyrrhiza 
labra (Licorice extract). The bulk of composition is alfalfa hay, soybean kernel, 
saccharose, calcium carbonate, oils and vegetable fats, magnesium hydroxide, and 
methyl-sulphonyl-methane. In Italy, Stucchi Luca et al. (2017) administered Gastrocure 
for 30 days to evaluate the efficacy of the product as a sole treatment option for equine 
gastric ulcerations in sport horses in training. The supplement was found to be effective 
in reducing gastric ulcer score and severity. Positive results may be due to various 
components of the supplement, including alfalfa hay, magnesium hydroxide and calcium 
carbonate, due to their buffering effects (Clark et al., 1996; Husted et al., 2008). Other 
nutrients that may have had added a protective effect for the gastric mucosa include 
threonine, Glycyrrhiza labra, aloe vera, antioxidant factors and mucilages. At the gastric-
enteric level, the amino acid threonine is involved in mucus production. Several studies 
have reported the efficacy of licorice in providing anti-ulcerogenic activity by 
suppressing acid secretion and increasing mucus secretion, along with promoting the 




reported that flavonoid, a content of licorice, could inhibit proton-pump activity in the 
GL mucosa (Beil et al., 1995; Kassir, 1985). Due to studies on humans and rats, the anti-
ulcerogenic capacity of aloe vera has been hypothesized due to its anti-inflammatory, 
cytoprotective, and mucus-stimulating effects (Langmead et al., 2004). Anti-
inflammatory effects were also found in horses (Lans et al., 2006). It is further 
hypothesized that aloe vera may act to increase the perfusion of gastric mucosa, which 
results in vasoconstriction and promotes angiogenesis, facilitating the healing of ulcers. 
Finally, mucilages which include pectin, guar, psyllium, and fenugreek in this case, form 
a viscous gel when in an acidic environment, protecting the mucosa from the harsh 
effects of the acidity (Ferrucci et al., 2003; Lans et al., 2006; Murray and Grady, 2002). 
Polysaccharide supplement  
Beta glucan  
 Several natural polysaccharides have been reported to have gastrointestinal 
protective effects (Ding et al., 2017; Oliveira et al., 2018; Wang et al., 2018). Beta glucan 
is a heterogenous polysaccharide that, as a dietary fiber, has the tendency to maintain 
blood glucose and cholesterol levels and produce short chain fatty acids to promote the 
growth of beneficial microflora (Guo et al., 2018; Xu et al., 2013). In rats, treatment with 
soluble dietary fiber protects the GI mucosa against NSAIDs (Satoh and Urushidani, 
2016). In 2019, Chen and colleagues revealed that beta glucan exerted protective effects 
on the gastric mucosa by alleviating neutrophil infiltration and lipid peroxidation through 
an antioxidant mechanism. Additionally, rats pretreated with beta glucan experienced a 




inhibition of pro-inflammatory cytokines. These results elucidate the antioxidant activity 
and anti-inflammatory potential of beta glucan (Chen et al., 2019).  
Hericium erinaceus  
 In a study with rats, when comparing mucosal injury of ethanol-induced 
ulceration, there are similar effects of pre-treatment omeprazole and H. erinaceus extract. 
Ulcer area significantly decreased, and mucus production increased in a dose-dependent 
manner in rats given varying levels of H. erinaceus extract. Rats under pre-treatment with 
H. erinaceus extract showed near-normal histopathological architecture of gastric mucosa 
comparable to normal rats, whereas those pre-treated with omeprazole presented with 
mild inflammation and infiltration of leukocytes in the stomach. Additionally, elevated 
production of reactive oxygen species (ROS) was indicated by decreased superoxide 
dismutase (SOD) levels, causing gastric damage to those in the control group. Higher 
doses of H. erinaceus extract caused a significant increase in SOD activity as well as 
prevented a depletion in catalase (CAT) activities (Chen et al., 2019).  
 Administration of H. erinaceus extract has protective effects on gastric mucosa 
and inhibits infiltration of leukocytes into the gastric wall in ethanol-induced gastric 
ulcers. A reduction in neutrophil infiltration has been a proven marker of ulcer healing 
(Shimizu et al., 2000). Leukocytes, specifically neutrophils, act as inflammatory 
mediators that can release ROS that are highly cytotoxic and induce tissue damage 
(Cheng and Koo, 2000). Thus, suppression of infiltration during inflammation might 




 The mucosal barrier plays a vital role in the protection of the gastric wall (Allen 
and Flemstrom, 2005). Free mucus was significantly increased in rats pre-treated with H. 
erinaceus extract in comparison with those in the ulcer control group. The mucus that 
adheres to the gastric wall protects the underlying epithelium from acid, pepsin and 
necrotizing agents (Alqasoumi et al., 2008).  
Hyaluronan  
 In 2011, Al-Bayaty and colleagues performed a study to evaluate the anti-
ulcerogenic activity of hyaluronic acid (HLA) against ethanol-induced gastric mucosal 
injury in rats (Al-Bayaty et al., 2009). Many tissues’ extracellular matrix is largely 
composed of HLA, a large non-sulfated glycosaminoglycan which is made up of 
repeating disaccharides of D-glucuronic and N-acetyl-glucosamine (Toole, n.d.). 
Fibroblasts are the primary secretors of HLA into the extracellular matrix (Mesa et al., 
n.d.). High molecular weight HLA is physiologically macro-aggregating and can perform 
action against hyaluronidase, an enzyme that breaks down proteoglycans (PG) in 
connective tissues and is effective at reconstructing when applied topically to damaged 
barriers. In a non-disease state, PG in the mucosal connective tissue act as a barrier 
against bacterial invasion and the spread of bacterial toxins.  
Biochemical Analytes 
Adenosine deaminase  
 Adenosine deaminase (ADA) is an critical enzyme involved in purine metabolism 
that functions as a catalyst, allosteric modulator, and cell-cell communication molecule 




therapeutic target for disease including catalytic activity, strict control of its concentration 
and its disruption of extracellular adenosine triphosphate (ATP) (Liu and Xia, 2015; Park 
and Gupta, 2013).  
 Extracellular purines (adenosine, ATP and ADP) and pyrimidines (UDP and 
UTP) are important signaling molecules that facilitate various biological processes such 
as the immune response and inflammation through purine receptors (Ralevic and 
Burnstock, 1998). Adenosine specifically functions as a signal to indicate tissue damage 
and inflammatory changes, and can act as a stress signal by autocrine or paracrine 
interactions (Camici et al., 2018; Kumar and Sharma, 2009). Adenosine can have 
different effects depending on target tissue, time course (Fredholm, 2007; Linden and 
Eltzschig, 2007) and receptor type, as various receptors have opposing functions 
(Fredholm, 2007; Linden and Eltzschig, 2007). Adenosine deaminase acts as an 
immunomodulatory and allosteric regulator by binding to adenosine receptors, and due to 
opposing functions of these receptors, can elicit pro- or anti-inflammatory effects, 
depending on immune status. An upregulation of ADA activity has been shown to result 
in inflammation and tissue injury, while a decrease in ADA activity has been associated 
with disease progression (da Silva et al., 2017; Saracoglu et al., 2005). 
Total antioxidant capacity 
 Oxidative stress is a key element of tissue injury in gastric disease, and intestinal 
insult has been directly linked to increased free radical production and a low 
concentration of endogenous defense mechanisms (Grisham, 1994; Kruidenier and 




significantly reduced and was independent of disease activity and localization 
(Koutroubakis et al., 2004). It is suggested that there is a relationship between serum 
TAC and mucosal antioxidant activity, measuring the totality of circulating antioxidants 
(Kampa et al., 2002; Malliaraki et al., 2003). Thus, it is a more accurate representation of 
chronic conditions instead of acute situations. A measured decrease in TAC may be 
attributable to several factors, including malabsorption and increased GI losses.  A 
reduction in antioxidant defense may result in the compromise of inflamed mucosa, 




















EQUINE GASTRIC ULCERS: POLYSACCHARIDE 
SUPPLEMENTTION AS A SOLUTION 
 
Introduction 
 The term “Equine Gastric Ulcer Syndrome” (EGUS) encompasses several 
disorders of the stomach and can be further defined by location. Distinguishing between 
Equine Squamous Gastric Disease (ESGD) and Equine Glandular Gastric Disease 
(EGGD) is imperative, as their pathophysiology and treatment needs vary. Hydrochloric 
acid (HCl) exposure, volatile fatty acid (VFA) injury, and the synergistic effect of bile 
acid and bacterial fermentation byproduct of non-structural carbohydrates (NSC) with 
HCl are major offenders of the squamous (SQ) mucosa. Successful injury resolution of 
SQ mucosa is widely achieved by the suppression of gastric acid. Pathophysiology of 
glandular (GL) mucosa is less well understood, but it is potential that nonsteroidal 
inflammatory drugs (NSAIDs) and bacteria play a role in the development of ulcers in 
this region. It has been found that GL ulcers require longer treatment duration than SQ 
ulcers, thus acid suppression coupled with therapies such as antimicrobials and mucosal 
coating agents show promise for efficient healing of the GL mucosa.  
 Omeprazole, a proton pump inhibitor (PPI), is the most common acid suppression 
therapy administered to horses suffering from ESGD and EGGD. It results in varying 
healing rates of the SQ and GL mucosa, is costly, and is not viable for long-term 
administration. The use of nutraceuticals and natural, long-term supplements are 




rates of efficacy are available including pectin-lecithin complexes, magnesium 
hydroxide, and sea buckthorn berries to name a few. More conclusively, high molecular 
weight hyaluronan (HA) has been proven to protect gastric mucosa from injury (Al-
Bayaty et al., 2009), and beta glucan supports enhanced gastroprotection and contains 
bioactive components with anti-ulcer activities (Wong et al., 2013). The goal of this 
research was to quantify the effect of a natural supplement containing HA and beta 
glucan, further referred to as “polysaccharide supplement” (PS), on SQ and GL ulcers in 
the equine stomach. 
Materials and Methods  
 This research was approved by the Institutional Animal Care and Use Committee 
of Clemson University (AUP #2020-013).  
Induction 
Gastric ulcers were induced in horses using a modified Murray method before 
onset of the 6-week supplemental period. Horses alternated four 12-hour periods of feed 
deprivation and normal feeding routine as well as two 24-hour feed deprivations leading 
up to the initial endoscopy (Day 0), for a total of 108 hours of feed deprivation. After 
ulcers were induced, horses underwent an initial pre-screening endoscopy (Day 0) to 
determine the extent of gastric ulcer presence in the SQ and GL regions of the stomach. 
These results were assessed, and scores of SQ and GL ulcerations were assigned. Prior to 
the other two examinations (Days 21 and 42), horses were fasted for 16 hours and water 






Endoscopic examinations were performed with a 3m long equine gastroscope by 
the same board-certified veterinarian on days 0, 21, and 42. Preparation for endoscopies 
included feed and water restrictions, as well as sedation. Once sedated, horses were 
secured in stocks prior to the beginning of the procedure. Before alterations to the gastric 
environment were made, stomach fluid samples from the proximal and distal regions 
were aspirated via 60mL syringe through the biopsy channel. During the endoscopic 
procedure, the stomach was distended by the insufflation of air until the SQ and GL 
regions were visible, then gastric contents were rinsed from the stomach surface using 
distilled water flushed through the biopsy channel. At the conclusion of the procedure the 
stomach was desufflated, the endoscope was withdrawn, and horses were recovered from 
sedation.  
Ulcer grading 
During the endoscopic examination, images were captured and digitized with a 
portable personal computer. Images of irritation, thickening of the mucosa, ulcers, and 
other abnormalities were captured. Location of the ulcers indicated further whether the 
horses had ESGD or EGGD. Lesion scores, assigned blindly by the veterinarian, ranged 








Table 1: Grading system for the squamous and glandular mucosa  
 Squamous mucosa Glandular mucosa 
Grade 0 The epithelium is intact 
and there is no appearance 
of hyperkeratosis 
The epithelium is intact 
and there is no evidence of 
hyperemia  
Grade 1 The mucosa is intact but 
there are areas of 
hyperkeratosis 
The mucosa is intact but 
there are areas of 
hyperemia 
Grade 2 Small, single, or multifocal 
(< 5) superficial lesions 
Small, single, or multifocal 
(< 5) superficial lesions 
Grade 3 Large, single deep or 
multiple (≥ 5) focal 
superficial lesions 
Large, single deep or 
multiple (≥ 5) focal 
superficial lesions 
Grade 4 Extensive lesions with 
areas of apparent deep 
ulceration 
Extensive lesions with 




 Eight mature geldings (Quarter Horse, Thoroughbred) were match-paired 
according to ulcer grade following the pre-screening endoscopy (Day 0). Horses ranged 
from 10 to 20 years in age and 534 to 643kg in body weight (BW) and were randomly 
assigned to one of two groups; treatment (TRT; n=4) or control (CTRL; n=4). The TRT 
horses received 1oz PS supplement top-dressed on their concentrate meals at 0600 and 
1800hrs daily for 6 weeks. The experiment was divided into three periods: pre-
supplementation (D 0), mid-supplementation (D 28), and post-supplementation (D 42). 
During each period, endoscopies were performed and stomach fluid samples were 
collected.  
Diet 
All horses were fed to meet or exceed the NRC suggested nutrient requirements 




pratensis) fed at a rate of 1.0% BW (as-fed) and a commercial concentrate (Nutrena® 
Triumph® Fiber Plus, Cargill®, Inc., Holmesville, OH) fed at a rate of 0.25% BW (as-
fed). Daily diets were separated into two meals fed at 0600 and 1800. Polysaccharide 
treatment (1oz) was fed to TRT horses at each meal. Composition of the supplement 
included purified water, liquid Aspergillus oryzae fermentation product, H. erinaceus 
(lion’s mane) extract, hyaluronan, sodium chloride, xanthan gum, citric acid, potassium 
sorbate and sodium benzoate (BioZyme®, Inc., St. Joseph, MO). There were no refusals 
of diet or treatment. Two 0.809ha pastures (PAS; n=4 horses per pasture) composed of 
fescue (Fescue pratensis), clover (Trifolium repens), annual rye (Lolium multiflorum) and 
other native grasses were utilized. Water was provided ad libitum.  
Management of horses 
All horses were weighed weekly with feed amounts adjusted accordingly. Horses 
were housed in 3.05x3.65m stalls and turned out into PAS from 0600-1800hrs and 1800-
0600hrs, respectively.  
After conclusion of the 6-week supplementation period, horses with remaining 
ulcerations upon final endoscopy (D 42) underwent oral omeprazole treatment based on 
severity. Those with scores 0-1 in the SQ and/or GL region were exempt from treatment. 
Those with scores of 2 or higher in the SQ region, GL region or both received a full dose 
of GastrogardÒ once daily on an empty stomach for 2 weeks. This was followed by a half 
dose or a 500lb dose, once daily for 2 weeks. Finally, the horses underwent a 250lb dose 
once daily for 2 weeks. Horses that underwent GastrogardÒ treatment were subject to an 





The effects of date and treatment were analyzed with a factorial ANOVA. All 
statistical calculations were performed using the software JMP.  
Results 
Ulcer scores  
 There was no difference between mean ulcer scores of TRT and CTRL groups 
across time (Figure 2.1; P=0.776). However, over the course of the 6-week supplemental 
period, all horses’ pooled SQ and GL ulcer scores decreased (Figure 2.2; P=0.001). 
While the overall main effect of ulcer scores between SQ and GL regions did not differ, 
at day 42 it was noted that SQ tissue presented with higher ulcer scores than GL (Figure 
2.3; P=0.006). Further, between TRT and CTRL horses, no difference was seen between 














Figure 2.1: Gastric ulcer scores on day 0, 21 and 42 of polysaccharide supplemented 
(TRT; n=4) versus non-supplemented horses (CTRL; n=4) 
 




Figure 2.2: Gastric ulcer scores on day 0, 21 and 42 of all experimental horses (n=8) 
 








Figure 2.3: Squamous (SQ) versus glandular (GL) gastric ulcer scores on day 0, 21 and 
42 of all experimental horses (n=8) 
 
*Indicates significant differences in squamous tissue ulcer scores compared to glandular 




Figure 2.4a: Squamous (SQ) gastric ulcer scores on day 0, 21 and 42 of polysaccharide 
supplemented horses (TRT; n=4) versus non-supplemented horses (CTRL; n=4) 
 





Figure 2.4b: Glandular (GL) gastric ulcer scores on day 0, 21 and 42 of polysaccharide 
supplemented horses (TRT; n=4) versus non-supplemented horses (CTRL; n=4) 
 
Main effect P > 0.05 
 
 Further statistical analyses were completed with the inclusion of a block for ulcer 
location (UL). In the SQ region, UL were defined as: 1 = near the margo plicatus (MP) 
and 2 = other than near the MP. In the GL region, UL were defined as: 3 = in the pyloric 
(P) region and 4 = other than in the P region. A difference was seen among all UL for 
both TRT and CTRL groups across time (Figure 2.5; P=0.0463). Despite these time 
differences, there was no overall difference between the SQ and GL regions of the TRT 










Figure 2.5: Ulcer scores in various areas (margo plicatus (MP), non-margo plicatus 
(NMP), pylorus (P) and non-pylorus (NP)) on day 0, 21 and 42 of all experimental horses 
(n=8) 
 
AB Ulcer location across days 0, 21 and 42 with different letters differ statistically (P< 
0.05) 
Main effect P<0.01 
 
Gastric pH  
 There was no difference in proximal or distal pH between TRT and CTRL groups 
across time (P=0.487). As expected, there was a difference between the pH values in the 














Figure 2.6: pH values of the proximal and distal regions of the equine stomach on day 0, 
21 and 42 of all experimental horses (n=8) 
 




 The severity of ulcer scores in all experimental horses indicated that the modified 
Murray induction method was adequate to test the hypothesis and to induce lesions to the 
gastric mucosa.  While there was no difference between mean ulcer scores of TRT and 
CTRL groups, there was an overall decrease in the horses’ pooled SQ and GL ulcer 
scores over the course of the 6-week supplemental period. This lack of difference may be 
attributable to the horses’ inactivity, as it has been shown that there is a strong 
relationship between exercise intensity and duration with prevalence, severity and 
number of lesion sites (Murray et al., 1996; Roy et al., 2005; Orsini et al., 2009). 
Moreover, the supplementation of polysaccharide therapy may have shown a lack of 




in maintaining mucosa of horses with naturally occurring ulcers. In another study 
concerning the effect of polysaccharides on equine gastric ulcers, supplementation was 
found to resolve or improve 90% of ulcerations in adult horses in active training (Slovis, 
2017). Additionally, adeptness of the mucosa to naturally heal should be considered, as 
CTRL horses had an improvement of 44% overall ulcer score, 17% SQ score, and 70% 
GL score over the 6-week supplemental period. There are several factors that may have 
aided in the natural healing process, the first being constant access to forage in the form 
of hay or pasture. In 2015, Sykes and colleagues highlighted the reduced risk of 
ulceration alongside free access or frequent feeding of fibrous roughage. Further, horses 
were fed minimal percentage of their BW in concentrates, thus non-structural 
carbohydrates, as recommended by the NRC. Since it has been shown that starch intake 
increases the likelihood of gastric ulceration, it is possible that the minimal offering of 
concentrates further contributed to the high natural healing rates (Luthersson et al., 
2009b).  
 No difference was found between the SQ and GL ulcer scores of all horses until 
day 42, where SQ ulcer scores were markedly higher than GL ulcer scores. This aligns 
with recent literature which found there is no relationship between ESGD and EGGD in 
the sense that one cannot be used as a predictor for the presence or absence of the other 
(Sykes et al., 2015a). Additionally, there was no difference of SQ and GL ulcer scores 
between TRT and CTRL groups. Given the differences in pathogenesis, prevalence and 
risk factors, it might be that after sufficient time, supplementation could potentially affect 




ulcers is a novel concept. Investigation on this subject is warranted as remarkable 
differences in healing rates have been recorded between SQ and GL ulcers with 
omeprazole treatment regarding duration of acid suppression, duration of treatment, and 
use of adjunctive therapies (Sykes et al., 2015a). Typically, GL ulcers require longer 
treatment duration than SQ ulcers, and treatment methods are targeted towards resolving 
the breakdown of natural barriers as opposed to reducing exposure to acidic injury. The 
SQ tissue can benefit from limiting contact of acidic gastric contents in order for 
intercellular tight junctions and intracellular buffering systems to regain function, and GL 
tissue has an opportunity to heal when coating agents form a pseudomucus layer, 
allowing for the tissue to regenerate the integrity of the mucosal layer. Pharmaceuticals 
and nutraceuticals can collaborate to create the most conducive environment for gastric 
healing. While acid suppression is currently the cornerstone for treatment of both SQ and 
GL tissues, the role of the efficacy of adding adjunctive therapies should not be 
dismissed.  
 Within the SQ and GL mucosa, there are areas that appear to be more prone to 
irritation and ulceration. The area surrounding the margo plicatus (MP) is a common 
lesion site in the SQ portion of the stomach, while the pyloric region (P) is where GL 
lesions are most commonly found. In the current study, of the SQ ulcerations observed, 
61% were present around the MP while 65% of GL ulcerations were in the P region. A 
difference was seen among ulcer locations (UL) for both TRT and CTRL groups across 
time. As of late, histopathological findings are being used in an attempt to differentiate 




excessive exposure to acidic gastric contents by thickening and becoming hyperkeratotic, 
which eventually results in the sloughing of the superficial layers of the mucosa. This 
leads to vulnerability of the mucosa to opportunistic bacteria, followed by the localized 
migration of inflammatory cells. The lesion will deepen, allowing for progression to 
ulceration, which fully exposes the tissue to acidic contents of the stomach (Martineau et 
al., 2009). This sequence of events occurs most commonly at the MP because it is the 
most vulnerable region of SQ tissue due to anatomical configuration of the equine 
stomach and its role as the intersection between the two tissue types. Thus, it is more 
prone to exposure to acidic gastric contents and does not possess the protective properties 
present in the GL mucosa. The process of spontaneous GL tissue ulceration is less 
understood. Excessive acid exposure does not seem to be a primary factor and studies 
speculating the harboring of an equine specific Helicobacter-like organism have yielded 
inconsistent results (Blikslager et al., 2017). Mucosal injury via refluxed bile acids should 
be considered, as this is a common occurrence in horses and can result in irritation to the 
mucosa. Interestingly, adaptive protection of the GL mucosa from the irritating effects of 
bile acids has been previously described, as injury typically occurs only when mucosal 
protective processes are impaired (Murray et al., 2001).  
 Though there were no differences of pH between the TRT and CTRL groups, 
there was a difference between the proximal and distal regions’ pH levels across all 
horses. Consistently, it was found that distal pH was lower than proximal pH. Literature 
supports that the pH in the distal region of the stomach is relatively stable around 3, 




pH did not drop below 4, so the presence of ulcers is contradictory to literature defining 
this threshold as ulcerogenic for SQ tissue (Husted et al., 2009). This difference may be 
due to the lack of an induction in horses in the aforementioned study.  
Conclusion 
 Polysaccharide supplementation at 1oz twice per day over a 6-week period did not 
have an effect on ulcer scores in the SQ or GL region. A significant recovery was seen by 
all experimental horses following the induction of gastric ulcers. The endoscopy on day 
42 revealed elevated SQ ulcer scores, supporting that healing rates of SQ and GL tissue 
are independent of each other. Additionally, the polysaccharide supplement did not 
influence pH values and all horses exhibited higher proximal than distal pH. The lack of 
effect may be due to conditions of induced ulcers, as studies involving naturally 
occurring ulcers have shown a more positive healing effect from polysaccharide 
supplementation. It may be beneficial to evaluate the efficacy of polysaccharide 














EQUINE GASTRIC ULCERS: ASSOCIATED BIOMARKERS  
 
Introduction 
 The prevalence of EGUS varies with breed, use, level of training, as well as 
between ESGD and EGGD (Sykes and Jokisalo, 2015). Up to 90% of performance horses 
are affected by gastric ulcers. Individual cases vary with clinical signs including reduced 
appetite, poor body condition, behavioral inconsistencies, and reduced performance, 
among others. There are many risk factors, with exercise and diet being the most 
influential. Currently, the only reliable antemortem diagnostic method for EGUS is 
endoscopy. This procedure involves feed and water restriction, as well as sedation.  
 Though it is definitive, the process of endoscopy is cost-prohibitive and is not 
accommodating to the equine stomach. As fasting is a risk factor for the development of 
ulcers, it seems counterintuitive to require it for diagnosis. The development of a salivary 
or serum panel for aid in the diagnostics of EGUS would provide a much less expensive 
and invasive method of determining gastric integrity.  
 Saliva, which is composed of 99% water, contains other compounds, hormones, 
and enzymes that have potential for aiding in diagnostics of systemic disorders. Saliva 
poses some advantages over blood collection, as it is non-invasive, non-stressful, and can 
be performed by those without training. Salivary analytes have been assessed in several 
species, including swine and equine, and usually revolve around markers indicative of 
stress response. There are minimal studies evaluating panels of analytes associated with 




confirmatory study in 2019 found several analytes that were elevated in horses with acute 
abdominal disease and also correlated with their respective serum concentrations 
(Contreras-Aguilar et al., 2019).  
 Though it is more invasive than saliva collection, blood collection for serum 
analysis is markedly less invasive and expensive than an endoscopic procedure, and the 
process can be taught with minimal training. Various biochemical markers are useful for 
measuring values such as oxidative stress, pathologic conditions, and immune response 
(Bagheri et al., 2019; Beyazit et al., 2012).  
 The goal of this research was to establish a relationship between salivary and 
serum analytes with gastric ulcer scores of the SQ and GL region of the equine stomach 
in order to potentiate a less-invasive diagnostic technique for EGUS.  
Materials and Methods  
 This research was approved by the Institutional Animal Care and Use Committee 
of Clemson University (AUP #2020-013).  
Experimental design 
 Eight mature geldings (Quarter Horse, Thoroughbred) were match-paired 
according to ulcer grade following the pre-screening endoscopy (Day 0). Horses ranged 
from 10 to 20 years in age and 534 to 643kg in body weight (BW) and were randomly 
assigned to one of two groups; treatment (TRT; n=4) or control (CTRL; n=4). The TRT 
horses received 1oz PS supplement top-dressed on their concentrate meals at 0600 and 
1800hrs daily for 6 weeks. The experiment was divided into three periods: pre-




During each period, endoscopies were performed and stomach fluid samples were 
collected. 
Diet 
All horses were fed to meet or exceed the NRC suggested nutrient requirements 
for horses at maintenance (NRC, 2007). Daily diets consisted of fescue hay (Festuca 
pratensis) fed at a rate of 1.0% BW (as-fed) and a commercial concentrate (Nutrena® 
Triumph® Fiber Plus, Cargill®, Inc., Holmesville, OH) fed at a rate of 0.25% BW (as-
fed). Daily diets were separated into two meals fed at 0600 and 1800. Polysaccharide 
treatment (1oz) was fed to TRT horses at each meal. Composition of the supplement 
included purified water, liquid Aspergillus oryzae fermentation product, H. erinaceus 
(lion’s mane) extract, hyaluronan, sodium chloride, xanthan gum, citric acid, potassium 
sorbate and sodium benzoate (BioZyme®, Inc., St. Joseph, MO). There were no refusals 
of diet or treatment. Two 0.809ha pastures (PAS; n=4 horses per pasture) composed of 
fescue (Fescue pratensis), clover (Trifolium repens), annual rye (Lolium multiflorum) and 
other native grasses were utilized. Water was provided ad libitum.  
Management of horses 
All horses were weighed weekly with feed amounts adjusted accordingly. Horses 
were housed in 3.05x3.65m stalls and turned out into PAS from 0600-1800hrs and 1800-
0600hrs, respectively.  
After conclusion of the 6-week supplementation period, horses with remaining 
ulcerations upon final endoscopy (D 42) underwent oral omeprazole treatment based on 




Those with scores of 2 or higher in the SQ region, GL region or both received a full dose 
of GastrogardÒ once daily on an empty stomach for 2 weeks. This was followed by a half 
dose or a 500lb dose, once daily for 2 weeks. Finally, the horses underwent a 250lb dose 
once daily for 2 weeks. Horses that underwent GastrogardÒ treatment were subject to an 
additional endoscopy after 2 weeks of treatment in order to assess efficacy (D 76). 
Biological sampling 
During each period, samples of saliva and blood were collected prior to 
endoscopic procedure. Though horses were in a fasted state, the mouth was rinsed of any 
remaining feedstuffs as a precautionary measure to avoid contamination. Saliva 
collection was performed by insertion of a 6.0x10-4m2 compressed sponge (Arcliber® 
cellulose sponge) through the bars of each horse’s mouth to be chewed until saturated 
with saliva. The procedure lasted approximately 90 seconds. Then, sponges were placed 
into salivette tubes after removal of the included cotton swab (Salivette Tubes, Fisher 
Scientific®) and were stored in a cooler until transport to Clemson University within the 
same day to be centrifuged at 3200rpm for 15 minutes. Following this, all were aliquoted 
into appropriately labeled microcentrifuge tubes (Eppendorf™ Tubes, Fisher Scientific®) 
and stored at -80°C.  
 Blood samples were collected by jugular venipuncture into Vacutainer® rapid 
serum test (RST) tubes via a double-ended bleeding needle (BD Vacutainer® Rapid 
Serum Tubes, Mississauga, ON). Blood samples were stored in a cooler until transport to 




Following this, all were aliquoted into appropriately labeled microcentrifuge tubes 
(Eppendorf™ Tubes, Fisher Scientific®) and stored at -80°C. 
Biochemical analyses 
Adenosine deaminase  
  The salivary and serum levels of ADA activity were quantified using an 
optimized adaptation of a commercial automatized assay (BioSystems S.A.; Gutiérrez et 
al., 2017). The method of the assay is based on the measurement of the decrease in 
absorbance (OD) per minute of a coupled reaction initially catalyzed by ADA. The 
reaction is measured at 340nm. The levels of ADA activity were calculated according to 
the manufacturer’s instructions (ΔOD/min x 3333 = U/L).  The optimal sample dilutions 
were 1:8 for saliva and 1:4 for serum samples. 
Cortisol and alpha amylase  
 The cortisol content in the salivary samples were measured using an optimized 
commercial competitive ELISA assay (Extended range high sensitivity salivary cortisol 
Enzyme immunoassay kit, Salimetrics, USA). No dilution of horse saliva was applied 
under the optimal conditions of the assay. Cortisol levels were calculated according to the 
manufacturer’s instructions (3 𝛍g/dL = 82.77 nmol/L).  
Total antioxidant capacity 
 The TAC was measured in the saliva and serum samples by the ferric reducing 
antioxidant power assay, which was optimized for the two-horse body-fluids (Benzi et 
al., 1996). The method consisted in the reduction of the ferric complex tripiridil triazine 




sample dilution was calculated using a standard curve of Trolox (a water-soluble analog 
of vitamin E employed as a control antioxidant agent for assay calibration), ranging from 
1.5 to 100 μM Trolox equivalents. No sample dilution was required. 
Total protein 
 The total protein content of serum and saliva samples was determined according 
to standard protocols (Bradford, 1976). A calibration curve with five standards based on 
bovine serum albumin was used with a concentration range of 5-100 ng/mL. For serum 
determinations, a sample dilution of 1:1000 was used while for saliva the optimal dilution 
for analysis was 1:20. 
Immunoglobulin levels 
 For the quantifications of serum IgG levels, serum samples were diluted at 
1:200000 for proper measurements using a commercial ELISA assay (IgG Horse ELISA 
kit, Abnova) according to the manufacturer’s instructions. The amount of salivary IgA 
was measured using an optimized commercial ELISA assay (IgA Horse ELISA kit, 




 There was no correlation between salivary total protein (TP), cortisol (CORT), 
and immunoglobulin A (IgA) concentrations and ulcer scores in the SQ or GL regions of 
the TRT or CTRL group. However, TRT horses’ adenosine deaminase (ADA) 




P=0.061; R2=0.308). In the CTRL group, there was a negative correlation between total 
antioxidant capacity (TAC) and GL ulcer scores (Figure 3.2; P=0.051; R2=0.330).  
 
Figure 3.1: Salivary adenosine deaminase (ADA) concentrations from day 0, 21 and 42 
sample collections in polysaccharide supplemented (TRT; n=4) and non-supplemented 
horses (CTRL; n=4) with glandular (GL) ulcers 
 
*Indicates trend for linear significance (P=0.061) 
Linear y = -0.0004x + 4.5387 

















Figure 3.2: Salivary total antioxidant capacity (TAC) concentrations in polysaccharide 
supplemented (TRT; n=4) and non-supplemented horses (CTRL; n=4) with glandular 
(GL) ulcers 
 
*Indicates significant linear trend (P=0.051) 
y = -0.0604x + 3.3768 
R² = 0.330 
Serum analytes 
 There was no correlation between serum ADA or TP concentrations with SQ 
ulcer scores of the TRT or CTRL group, nor any correlation between serum TAC 
concentration in the TRT group. There was no correlation between serum ADA 
concentration in the CTRL group, TAC in both groups nor TP concentration in the TRT 
group with GL ulcer scores. However, there was a strong positive correlation found 
between serum TAC and SQ scores in the CTRL group (Figure 3.3; P=0.002; R2=0.620). 
In the TRT group, a positive correlation was found for serum ADA and GL ulcer scores 
(Figure 3.4; P=0.028; R2=0.399). In the CTRL group, a negative correlation was found 





Figure 3.3: Serum total antioxidant capacity (TAC) levels in polysaccharide 
supplemented (TRT; n=4) and non-supplemented horses (CTRL; n=4) with squamous 
(SQ) ulcers  
 
*Indicates significant linear trend (P=0.002) 
y = 0.2952x - 3.717 
R² = 0.62 
Figure 3.4: Serum adenosine deaminase (ADA) levels in polysaccharide supplemented 
(TRT; n=4) and non-supplemented horses (CTRL; n=4) with glandular (GL) ulcers  
 
*Indicates significant linear trend (P=0.028) 
y = 0.0199x - 3.1444 





Figure 3.5: Serum total protein (TP) levels in polysaccharide supplemented (TRT; n=4) 
and non-supplemented horses (CTRL; n=4) with glandular (GL) ulcers  
 
*Indicates significant linear trend (P=0.016) 
y = -0.0553x + 6.2617 
R² = 0.456 
Discussion 
 A negative correlation was found between salivary adenosine deaminase (ADA) 
and GL ulcer scores of the TRT group, meaning ADA concentrations were increased in 
TRT horses with lower GL ulcer scores. This contradicts findings in studies observing 
salivary analytes in swine, in which ADA concentrations were increased by acute stress 
or pathologic conditions (Contreras-Aguilar et al., 2019; Tecles et al., 2018, 2017). 
However, it has been found that ADA can have either pro- or anti-inflammatory effects, 
depending on immune status, due to differences in response to various receptors. It is 
possible that levels of ADA are increased in horses with lower GL scores due to working 
as an anti-inflammatory agent. There are cases in humans in which decreased ADA 




This is most likely by mechanism of neutralizing the upregulated purine and DNA 
metabolism, and the effects on tissues will depend on the length of time that has passed 
from the initial injury (Bagheri et al., 2019). 
 Salivary total antioxidant capacity (TAC) concentrations had a negative 
correlation with the GL scores of the horses in the TRT group. The negative correlation is 
especially unprecedented in the TRT group, as the particular polysaccharide in the 
supplement has been shown to reduce free radicals in the body, acting as an antioxidant 
(Brindzova et al., 2008). This contradictory result may be due to the salivary sampling 
method, or the use of a low of a molecular weight beta-glucan (Błaszczyk et al., 2015). 
 A positive correlation was present between serum TAC concentrations and SQ 
ulcer scores in the CTRL group. The involvement of free radicals is known to be 
involved in the genesis of gastric ulcers as well as other malignancies of the GI tract 
(Tandon et al., 2004). Free radical accumulation is modulated by antioxidant enzymes, 
and when these factors are imbalanced the reactive oxygen species (ROS) cause tissue 
damage. 
 Serum ADA levels correlated positively with GL ulcer scores of TRT horses such 
that as ADA concentrations increased, the GL ulcer scores did as well. ADA 
concentration increases with various diseases, which may be due to its macrophage and 
monocyte lineage, reflecting the immune response (Bagheri et al., 2019). In humans with 
GI disease, serum ADA levels were elevated, suggesting a fractional role of activated T-
cell response in the disease pathophysiology (Beyazit et al., 2012). Increased ADA 




gastrointestinal (GI) tract. Catabolic degradation of adenosine by ADA may result in 
impairment of immune modulation by adenosine, resulting in the worsening of 
inflammation and tissue injury (Antonioli et al., n.d.; Vieira et al., 2014). Adenosine has 
the potential to mediate pro-inflammatory and/or anti-inflammatory and 
immunosuppressant activities in gut diseases in humans and rats, but more research is 
needed to assess the efficacy of this therapy in equine GI disease. 
Conclusion  
Specific salivary and serum analytes correlated variously with ulcers in the SQ 
and GL regions of the equine stomach. Of the salivary analytes, ADA and TAC showed 
relationships with ulcer scores. The GL ulcer scores of the TRT group correlated 
negatively with salivary ADA concentrations, potentially due to the effect of time from 
initial tissue injury. Additionally, the GL scores of the TRT group correlated negatively 
with salivary TAC concentrations, possibly due to the oxidative stress occurring in the 
damaged tissue. Of the serum analytes, ADA, TAC and TP showed relationships with 
ulcer scores. The GL scores of the TRT group correlated positively with serum ADA 
concentrations, likely due to an immune and inflammatory response. The SQ scores of 
the CTRL group correlated positively with serum TAC concentrations, posing an 
unexpected relationship that may be due to acute rather than chronic ulcerations. The GL 
scores of the CTRL group correlated negatively with serum TP concentrations, 









The results of this study indicate that polysaccharide supplementation at 1oz twice 
daily over a 6-week period does not have an effect on ulcer scores in the SQ or GL region 
of the equine stomach in a fasting-induced model. It is possible that the induced model is 
not the most proficient way of assessing the efficacy of the supplement as both the TRT 
and CTRL groups healed at the same rate over the 6-week period. In addition, the lack of 
common risk factors such as intermittent forage availability, exercise, and transportation 
may have contributed to high natural healing rates. The inconsistent improvement of 
scores between the SQ and GL ulcers further supports the novel concept of tailoring 
treatment to the region of ulceration, as the pathophysiology and healing rates of the two 
tissue types differ greatly. Further, predisposition of common areas to ulceration due to 
anatomical configuration of the stomach is an important factor to consider for treatment. 
Consistent with literature, there was an average ventral pH of around 3. Due to the 
horses’ fasted state, cardiac pH averaged around 4, though under normal conditions it is 
typically around 7. As the ulcerogenic threshold for SQ ulceration has been defined at a 
pH of 4, exploration of diagnostic or screening methods outside of endoscopies should be 
pursued due to the procedure’s required fasting.  
There were correlations of several salivary and serum analytes with ulcerations of 
various regions in the equine stomach. Of the salivary analytes, ADA and TAC showed 
relationships with ulcer scores. The GL ulcer scores of the TRT group correlated 




initial tissue injury. Additionally, the GL scores of the TRT group correlated negatively 
with salivary TAC concentrations, possibly due to the oxidative stress occurring in the 
damaged tissue. Of the serum analytes, ADA, TAC and TP showed relationships with 
ulcer scores. The GL scores of the TRT group correlated positively with serum ADA 
concentrations, likely due to an immune and inflammatory response. The SQ scores of 
the CTRL group correlated positively with serum TAC concentrations, posing an 
unexpected relationship that may be due to acute rather than chronic ulcerations. The GL 
scores of the CTRL group correlated negatively with serum TP concentrations, 
potentially due to low hydration levels of horses post-fasting and water withdrawal. 
The data represented in this study provide a valuable basis for the continued 
pursuit of knowledge concerning the efficacy of polysaccharide supplementation on 
naturally occurring ulcers, as well as developing a less invasive diagnostic or screening 
technique for detecting equine gastric ulcers. Additional research involving a non-
induced model and non-fasted collection of biological samples may further define the 
effect of polysaccharide supplementation on equine gastric ulcers and provide a more 
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